580556 Sigma-AldrichPaclitaxel, Semi-Synthetic - CAS 33069-62-4 - Calbiochem
A semi-synthetic form of Paclitaxel having no contamination by natural taxanes. Also has reduced levels of epimerization products as contaminants.
More>> A semi-synthetic form of Paclitaxel having no contamination by natural taxanes. Also has reduced levels of epimerization products as contaminants. Less<<Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
33069-62-4 | C₄₇H₅₁NO₁₄ |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
580556-5MG |
|
Plastic ampoule | 5 mg |
|
— |
Description | |
---|---|
Overview | A semi-synthetic form of Paclitaxel (Cat. No. 580555) having no contamination by natural taxanes. Also has reduced levels of epimerization products as contaminants. |
Catalogue Number | 580556 |
Brand Family | Calbiochem® |
Product Information | |
---|---|
CAS number | 33069-62-4 |
ATP Competitive | N |
Form | Crystalline solid |
Hill Formula | C₄₇H₅₁NO₁₄ |
Chemical formula | C₄₇H₅₁NO₁₄ |
Reversible | N |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Promotes assembly of microtubules and inhibits tubulin disassembly. |
Purity | ≥97% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | DA8340700 |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
580556-5MG | 04055977265538 |
Documentation
Paclitaxel, Semi-Synthetic - CAS 33069-62-4 - Calbiochem MSDS
Title |
---|
Paclitaxel, Semi-Synthetic - CAS 33069-62-4 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
580556 |
References
Reference overview |
---|
Derry, W.B., et al. 1995. Biochemistry 34, 2203. Milas, L., et al. 1995. Cancer Chemother. Pharmacol. 35, 297. Donaldson, K.L., et al. 1994. Int. J. Cancer 57, 847. Hornback, N.B., et al. 1994. In Vivo 8, 819. Manthey, C.L., et al. 1992. J. Immunol. 149, 2459. Rowinsky, E.K., et al. 1992. Semin. Oncol.19, 646. Ding, A.H., et al. 1990. Science 248, 370. Mogensen, M.M. and Tucker, J.B. 1990. J. Cell Sci. 97, 101. Slichenmeyer, W.J. and Von Hoff, D.D. 1990. J. Clin. Pharmacol. 30, 770. |